CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 67.52 CNY -4.43% Market Closed
Market Cap: 7.7B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Income Statement

Earnings Waterfall
CanSino Biologics Inc

Revenue
634.6m CNY
Cost of Revenue
-271.2m CNY
Gross Profit
363.4m CNY
Operating Expenses
-1.2B CNY
Operating Income
-878.1m CNY
Other Expenses
11.4m CNY
Net Income
-866.7m CNY

Income Statement
CanSino Biologics Inc

Rotate your device to view
Income Statement
Currency: CNY
Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
0
N/A
4
N/A
4
N/A
6
+41%
19
+227%
487
+2 526%
2 082
+327%
3 104
+49%
4 300
+39%
4 332
+1%
2 868
-34%
1 921
-33%
1 035
-46%
636
-39%
531
-16%
603
+14%
357
-41%
471
+32%
635
+35%
Gross Profit
Cost of Revenue
0
(0)
0
(2)
(14)
(241)
(645)
(1 069)
(1 298)
(1 231)
(896)
(498)
(1 218)
(343)
(365)
(425)
(801)
(316)
(271)
Gross Profit
0
N/A
4
N/A
0
N/A
4
N/A
5
+16%
246
+5 099%
1 436
+483%
2 035
+42%
3 002
+47%
3 101
+3%
1 972
-36%
1 423
-28%
(184)
N/A
293
N/A
167
-43%
178
+7%
(444)
N/A
156
N/A
363
+133%
Operating Income
Operating Expenses
(201)
(243)
(262)
(356)
(413)
(775)
(1 026)
(1 139)
(1 203)
(1 144)
(1 146)
(1 733)
(1 274)
(2 072)
(2 983)
(2 465)
(1 245)
(2 328)
(1 241)
Selling, General & Administrative
(66)
(82)
(80)
(106)
(96)
(147)
(210)
(274)
(326)
(408)
(440)
(487)
(545)
(569)
(725)
(700)
(621)
(746)
(580)
Research & Development
(137)
(171)
(217)
(286)
(409)
(735)
(921)
(956)
(851)
(766)
(651)
(772)
(731)
(771)
(942)
(841)
(568)
(735)
(486)
Depreciation & Amortization
(17)
(22)
(26)
0
(23)
0
0
0
(40)
0
0
0
(55)
0
0
0
(112)
0
0
Other Operating Expenses
19
31
62
36
114
108
104
91
14
31
(55)
(474)
58
(731)
(1 316)
(924)
55
(848)
(176)
Operating Income
(201)
N/A
(239)
-19%
(258)
-8%
(352)
-37%
(409)
-16%
(528)
-29%
410
N/A
896
+118%
1 798
+101%
1 957
+9%
826
-58%
(310)
N/A
(1 458)
-370%
(1 779)
-22%
(2 817)
-58%
(2 286)
+19%
(1 689)
+26%
(2 172)
-29%
(878)
+60%
Pre-Tax Income
Interest Income Expense
44
16
46
20
11
37
74
121
142
122
238
310
277
284
243
143
115
61
(46)
Non-Reccuring Items
(0)
0
0
0
1
0
0
0
(0)
0
0
0
(0)
0
0
0
(363)
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
Total Other Income
(0)
43
(0)
46
(0)
5
(16)
(21)
(4)
(5)
(5)
(0)
(3)
(10)
(52)
(51)
(43)
(42)
(1)
Pre-Tax Income
(157)
N/A
(180)
-15%
(212)
-18%
(286)
-35%
(397)
-39%
(486)
-23%
469
N/A
996
+112%
1 937
+94%
2 073
+7%
1 058
-49%
(0)
N/A
(1 184)
-259 715%
(1 505)
-27%
(2 626)
-74%
(2 194)
+16%
(1 979)
+10%
(2 154)
-9%
(925)
+57%
Net Income
Tax Provision
0
0
0
0
0
0
100
44
(30)
(36)
(72)
85
219
256
193
93
11
0
9
Income from Continuing Operations
(157)
(180)
(212)
(286)
(397)
(486)
569
1 039
1 907
2 037
986
85
(965)
(1 249)
(2 433)
(2 101)
(1 967)
(2 142)
(915)
Income to Minority Interest
0
0
0
0
0
2
0
0
7
13
3
22
55
79
531
542
485
489
49
Net Income (Common)
(157)
N/A
(180)
-15%
(212)
-18%
(286)
-35%
(397)
-39%
(484)
-22%
569
N/A
1 039
+83%
1 914
+84%
2 050
+7%
989
-52%
106
-89%
(909)
N/A
(1 170)
-29%
(1 903)
-63%
(1 560)
+18%
(1 483)
+5%
(1 653)
-11%
(867)
+48%
EPS (Diluted)
-0.77
N/A
-0.8
-4%
-0.95
-19%
-1.24
-31%
-1.72
-39%
-2.07
-20%
2.29
N/A
4.19
+83%
7.74
+85%
8.29
+7%
4
-52%
0.43
-89%
-3.68
N/A
-4.78
-30%
-7.71
-61%
-6.32
+18%
-6.01
+5%
-6.67
-11%
-3.51
+47%

See Also

Discover More